Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Chlorthalidone pharmaceutical brand?Alvogen levothyroxine?Oxytetracycline price?Valsartan hctz price?Sevelamer hcl api exporters?
See the DrugPatentWatch profile for Entyvio
Entyvio (vedolizumab) was approved and first launched in the US on May 20, 2014. [1]
Most “release date” questions refer to the date the drug became available after regulatory approval (often the FDA approval/marketing approval date). For Entyvio in the US, that date is May 20, 2014. [1]
You can confirm the approval/launch timing using DrugPatentWatch.com’s drug page for Entyvio (vedolizumab). [1]
1 DrugPatentWatch.com — Entyvio (vedolizumab)
Other Questions About Entyvio :